{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-25-000134","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2025-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.502449+00:00","generated_at":"2026-05-16T12:59:35.787959+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"INNOVATE's MediBeacon receives FDA approval for next-gen TGFR System","bullets":["MediBeacon (44.7%-owned by VATE) gets FDA nod for TGFR System with reusable sensor.","Reusable sensor lowers cost vs prior single-use version; designed for patient comfort.","Initial sales at select US and China academic medical centers expected Q1 2026.","TGFR System featured as lead article in Journal of the American Society of Nephrology August 2025.","Transdermal GFR assessment does not require age, weight, sex, race, or ethnicity inputs."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-25-000134","json":"https://secwatch.observer/filing/0001006837-25-000134.json","markdown":"https://secwatch.observer/filing/0001006837-25-000134.md","text":"https://secwatch.observer/filing/0001006837-25-000134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/0001006837-25-000134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/hchc-20251216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:59:35.787959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}